Basic information
- CAS
521-18-6- Standard SMILES
C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12- InChIKey
NVKAWKQGWWIWPM-ABEVXSGRSA-N- Molecular formula
- C19H30O2
- Average molar mass
- 290.4 g/mol
- Monoisotopic mass
- 290.2245802
Overview
17beta-hydroxy-5alpha-androstan-3-one is a 17beta-hydroxy steroid that is testosterone in which the 4,5 double bond has been reduced to a single bond with alpha-configuration at position 5. It has a role as an androgen, a mouse metabolite, a human metabolite and a Daphnia magna metabolite. It is a 3-oxo-5alpha-steroid, a 17beta-hydroxy steroid and a 17beta-hydroxyandrostan-3-one. It derives from a hydride of a 5alpha-androstane.
Names & identifiers
- Preferred name
- Dihydrotestosterone
- IUPAC
- (5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one
- English name
- Stanolone
- Molecular formula
- C19H30O2
- Molecular weight
- 290.45
Names & synonyms
Show more names
Database identifiers
- CAS
521-18-6- PubChem CID
- 10635
- DTXSID
DTXSID9022364- ChEMBL
CHEMBL27769- ChEBI
CHEBI:16330- UNII
- 08J2K08A3Y
- EC Number
- 208-307-3
- Nikkaji
- J39.503J
Properties
Computed structural properties
- XLogP
- 3.7
- Topological polar surface area
- 37.3 Ų
- Hydrogen bond donors
- 1
- Hydrogen bond acceptors
- 2
- Rotatable bonds
- 0
- Heavy atoms
- 21
- Formal charge
- 0
- Complexity
- 458
Experimental & physicochemical properties
Drugs
DEA NFLIS-Drug Category -> Steroids
DEA Schedule III Controlled Substance -> Anabolic steroids
Pharmaceuticals -> Synthetic Cannabinoids or Psychoactive Compounds
Physicochemical properties
- Melting point
- 178 · 178-183 °C
- alpha
- 27 · 27 º
- Boiling point
- 372.52 °C · 372.52°C (rough estimate)
- Density
- 1.032 · 1.0320 (rough estimate)
- refractive index
- 1.4709 · 1.4709 (estimate)
- Flash point
- 9 ℃ · 9℃
- storage temp.
- 2 · 2-8°C
- solubility
- 1 mg/ml; · Acetonitrile: 1 mg/ml; Ethanol: 1 mg/ml; Methanol: 1 mg/ml
- pka
- 15.08 · 15.08±0.60(Predicted)
- form
- powder
- biological source
- synthetic
- optical activity
- 20 · [α]20/D +33±1°, c =1% in ethanol
- Water Solubility
- 344.3 g/L · 344.3g/L(temperature not stated)
- Merck
- 13 · 13,8872
- BRN
- 2056371 · 2056371
- Major Application
- forensics and toxicologypharmaceutical (small molecule)
- InChI
- 1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12,14-17,21H,3-11H2,1-2H3/t12-,14-,15-,16-,17-,18-,19-/m0/s1
- InChIKey
- NVKAWKQGWWIWPM-ABEVXSGRSA-N
- SMILES
- [H][C@@]12CC[C@@]3([H])[C@]4([H])CC[C@H](O)[C@@]4(C)CC[C@]3([H])[C@@]1(C)CCC(=O)C2
- CAS DataBase Reference
- 521 · 521-18-6(CAS DataBase Reference)
- NCI Dictionary of Cancer Terms
- androstanolone; DHT; dihydrotestosterone
- FDA UNII
- 8 J2K08A3Y · 08J2K08A3Y
- NCI Drug Dictionary
- dihydrotestosterone
- ATC code
- 14 AA01,G03BB02 · A14AA01,G03BB02
- NIST Chemistry Reference
- Stanolone(521-18-6)
- EPA Substance Registry System
- -3 · Androstan-3-one, 17-hydroxy-, (5.alpha.,17.beta.)- (521-18-6)
- UNSPSC Code
- 51111800 · 51111800
- NACRES
- 77 · NA.77
- Symbol(GHS)
- 7 · GHS07,GHS08,GHS09
- Signal word
- Danger
- Hazard statements
- 302 · H302-H351-H360FD-H410
- Precautionary statements
- 202 · P202-P264-P270-P273-P301+P312-P308+P313
- PPE
- 3 · Eyeshields, Gloves, type P3 (EN 143) respirator cartridges
- Hazard Codes
- Xn,T,F
- Risk Statements
- 61 · 61-40-39/23/24/25-23/24/25-11
- Safety Statements
- 53 · 53-36/37/39-45-36/37-16
- RIDADR
- 1230 · UN1230 - class 3 - PG 2 - Methanol, solution
- WGK Germany
- 3 · 3
- RTECS
- 8052000 · BV8052000
- Storage Class
- 6.1 C · 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
- Hazard Classifications
- 4 OralAquatic · Acute Tox. 4 OralAquatic Acute 1Aquatic Chronic 1Carc. 2Repr. 1A
- REACH Registrations
- Inactive
Safety & regulation
GHS classification
GHS Classification
Danger
H351 (98.3%): Suspected of causing cancer [Warning Carcinogenicity]
P203, P280, P318, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 60 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Hazard information
Regulatory Information
DEA schedule III controlled substance
Status: Cease Manufacture Update: 31-10-2012 https://echa.europa.eu/registration-dossier/-/registered-dossier/12136
Toxicology
Drug Induced Liver Injury
Drug-Induced Liver Injury Severity and Toxicity (DILIst)
ANDROSTANOLONE
DILI Positive
DOI:10.1016/j.drudis.2019.09.022
USGS Health-Based Screening Levels for Evaluating Water-Quality
Dihydrotestosterone
Hormone
Smith, C.D. and Nowell, L.H., 2024. Health-Based Screening Levels for evaluating water-quality data (3rd ed.). DOI:10.5066/F71C1TWP
Safety data
- PPE
- Eyeshields, Gloves, type P3 (EN 143) respirator cartridges
- wgk
- 3
- rtecs
- BV8052000
- ridadr
- UN1230 - class 3 - PG 2 - Methanol, solution
- risk_code
- 61-40-39/23/24/25-23/24/25-11
- Signal word
- Danger
- Symbol(GHS)
- GHS07,GHS08,GHS09
- hazard_code
- Xn,T,F
- safety_code
- 53-36/37/39-45-36/37-16
- Storage Class
- 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
- Hazard statements
- H302-H351-H360FD-H410
- REACH Registrations
- Inactive
- Hazard Classifications
- Acute Tox. 4 OralAquatic Acute 1Aquatic Chronic 1Carc. 2Repr. 1A
- Precautionary statements
- P202-P264-P270-P273-P301+P312-P308+P313
Chemistry & industry
Pharmacology
ATC Code
A - Alimentary tract and metabolism
G - Genito urinary system and sex hormones
QA - Alimentary tract and metabolism
QG - Genito urinary system and sex hormones
MeSH Pharmacological Classification
Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power.
Uses & manufacturing
Applications
DescriptionStanolone is well known as dihydrotestosterone (DHT), which is an endogenous androgen sex steroid and hormone. It is an agonist of the androgen receptor (AR). It plays important physiological role in sexual differentiation, maturation of the penis and scrotum, hair, sebum production and development and maintenance of the prostate gland and seminal vesicles. It is mainly used for the treatment of male hypogonadism, androgen deficiency of severe illness, androgen deficiency of ageing and microphallus in infancy.
UsesStanolone is a potent androgenic metabolite of testosterone that It is Controlled substance. It was created for the treatment of muscle wasting disease, and osteoporosis. It is a powerful anabolic steroid, which is similar to the body's naturally produced Dihydrotestosterone. Dihydrotestosterone (DHT) is generated by a 5-alpha reduction of testosterone. Unlike testosterone, DHT cannot be aromatized to estradiol therefore DHT is considered a pure androgenic steroid.
General DescriptionDihydrotestosterone (Item No. 15874) is an analytical reference standard categorized as an anabolic androgenic steroid. Anabolic steroids, including dihydrotestosterone, have been used to enhance physical performance in athletes. Dihydrotestosterone is regulated as a Schedule III compound in the United States. This product is intended for research and forensic applications.
Upstream & downstream products
Upstream raw materials
Downstream products
Suppliers100 total
Additional notes
DefinitionChEBI: Stanolone is a 17beta-hydroxy steroid that is testosterone in which the 4,5 double bond has been reduced to a single bond with alpha-configuration at position 5. It has a role as an androgen, a human metabolite, a Daphnia magna metabolite and a mouse metabolite. It is a 17beta-hydroxy steroid, a 17beta-hydroxyandrostan-3-one and a 3-oxo-5alpha-steroid. It derives from a hydride of a 5alpha-androstane.
Related reactions
Compound notes
Loading…